Biotech comes to its 'antisenses' after hard-won drug approval
Biotech comes to its 'antisenses' after hard-won drug approval"
- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:
Access through your institution Buy or subscribe “With any brand new technology, you never know when the world will be ready for it.” So said Paul Boni, an analyst at Punk, Ziegel &
Knoll, in 1998 (as quoted by the _New York Times_), after the US Food and Drug Administration (FDA) approved its first gene-silencing 'antisense therapy', a drug known as Vitravene
(fomivirsen), for the treatment of cytomegalovirus infections in individuals with weakened immune systems. The arrival of Vitravene, a short strand of 21 DNA molecular units that blocks
viral replication, was hailed as a major milestone for the biotech industry and was widely anticipated to usher in a new era of antisense products. But no more came. And by the middle of the
last decade, Isis Pharmaceuticals, the Carlsbad, California–based company behind Vitravene, ended up pulling the therapy from the market because improvements in other antiretrovirals had
effectively eliminated the drug's target market. Boni's cautionary words proved all too prescient. This is a preview of subscription content, access via your institution RELEVANT
ARTICLES Open Access articles citing this article. * DNA/RNA HETERODUPLEX OLIGONUCLEOTIDE FOR HIGHLY EFFICIENT GENE SILENCING * Kazutaka Nishina * , Wenying Piao * … Takanori Yokota _Nature
Communications_ Open Access 10 August 2015 * MERKEL CELL CARCINOMA: EPIDEMIOLOGY, TARGET, AND THERAPY * Mathew P. Hughes * , Matthew E. Hardee * … Ling Gao _Current Dermatology Reports_
Open Access 22 January 2014 ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 12 print issues and online access $209.00 per year only $17.42 per issue Learn
more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS
OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support Authors * Kevin Jiang View author publications You can also search for this author
inPubMed Google Scholar RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Jiang, K. Biotech comes to its 'antisenses' after hard-won drug
approval. _Nat Med_ 19, 252 (2013). https://doi.org/10.1038/nm0313-252 Download citation * Published: 06 March 2013 * Issue Date: March 2013 * DOI: https://doi.org/10.1038/nm0313-252 SHARE
THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to
clipboard Provided by the Springer Nature SharedIt content-sharing initiative
Trending News
Chandigarh lok sabha election result 2024 live updates: congress' manish tewari has won this seatCHANDIGARH LOK SABHA ELECTION RESULT 2024 LIVE UPDATES: With the counting of votes for the 2024 Lok Sabha elections unde...
Can't walk, will smokeCan't walk, will smoke Published on: 15 Nov 1997, 12:00 am _British Medical Journal_ Down To Earth www.downtoearth...
'extraordinary resources' needed in c diff fight | nursing timesControlling the spread of C diff may require “extraordinary resources”, an expert has warned. Dr Mark Miller said that w...
Kerala hc orders inquiry into charges of false date, venue on vaccine certificatesThe court was hearing a plea by one K P John, moved through advocates C Dileep and Anushka Vijayakumar, alleging falsifi...
World war 3 alert: china and india move troops to borderCHINA'S RISE IN AGGRESSION MEANS 'DEMISE IN THE WEST' SAYS MP Fears the increasingly bitter dispute could...
Latests News
Biotech comes to its 'antisenses' after hard-won drug approvalAccess through your institution Buy or subscribe “With any brand new technology, you never know when the world will be r...
Robert durst is eager to clear his name: lawyerThe eminent Texas litigator leading New York real estate heir and suspected murderer Robert Durst’s defense team tells P...
404 Not Found!You're using an Ad-Blocker. BeforeItsNews only exists through ads.We ask all patriots who appreciate the evil we expose ...
Feeling connected enhances mental and physical health – here are 4 research-backed ways to find moments of connection with loved ones and strangersA woman and her fiancé joke and laugh together while playing video games after a long day. A college freshman interrupts...
British orthodontics | British Dental JournalARTICLE PDF Authors * D Roberts-Harry View author publications You can also search for this author inPubMed Google Schol...